Alterations of the interactome of Bcl-2 proteins in breast cancer at the transcriptional, mutational and structural level Konig, Simon Mathis; Rissler, Vendela; Terkelsen, Thilde; Lambrughi, Matteo; Papaleo, Elena Published in: P L o S One DOI: 10.1371/journal.pcbi.1007485 Publication date: 2019 Document version Publisher's PDF, also known as Version of record Citation for published version (APA): Konig, S. M., Rissler, V., Terkelsen, T., Lambrughi, M., & Papaleo, E. (2019). Alterations of the interactome of Bcl-2 proteins in breast cancer at the transcriptional, mutational and structural level. P L o S One, 15(12), [e1007485]. https://doi.org/10.1371/journal.pcbi.1007485 Download date: 25. sep.. 2021 RESEARCH ARTICLE Alterations of the interactome of Bcl-2 proteins in breast cancer at the transcriptional, mutational and structural level Simon Mathis Kønig1, Vendela Rissler1, Thilde Terkelsen1, Matteo Lambrughi1, 1,2 Elena PapaleoID * 1 Computational Biology Laboratory, Danish Cancer Society Research Center, Copenhagen, Denmark, a1111111111 2 Translational Disease Systems Biology, Faculty of Health and Medical Sciences, Novo Nordisk Foundation Center for Protein Research University of Copenhagen, Copenhagen, Denmark a1111111111 a1111111111 *
[email protected] a1111111111 a1111111111 Abstract Apoptosis is an essential defensive mechanism against tumorigenesis. Proteins of the B- OPEN ACCESS cell lymphoma-2 (Bcl-2) family regulate programmed cell death by the mitochondrial apopto- sis pathway. In response to intracellular stress, the apoptotic balance is governed by inter- Citation: Kønig SM, Rissler V, Terkelsen T, Lambrughi M, Papaleo E (2019) Alterations of the actions of three distinct subgroups of proteins; the activator/sensitizer BH3 (Bcl-2 homology interactome of Bcl-2 proteins in breast cancer at 3)-only proteins, the pro-survival, and the pro-apoptotic executioner proteins.